Skip to main content
Top
Published in: Malaria Journal 1/2016

Open Access 01-12-2016 | Review

Psychiatric effects of malaria and anti-malarial drugs: historical and modern perspectives

Authors: Remington L. Nevin, Ashley M. Croft

Published in: Malaria Journal | Issue 1/2016

Login to get access

Abstract

The modern medical literature implicates malaria, and particularly the potentially fatal form of cerebral malaria, with a risk of neurocognitive impairment. Yet historically, even milder forms of malaria were associated in the literature with a broad range of psychiatric effects, including disorders of personality, mood, memory, attention, thought, and behaviour. In this article, the history of psychiatric effects attributed to malaria and post-malaria syndromes is reviewed, and insights from the historical practice of malariotherapy in contributing to understanding of these effects are considered. This review concludes with a discussion of the potentially confounding role of the adverse effects of anti-malarial drugs, particularly of the quinoline class, in the unique attribution of certain psychiatric effects to malaria, and of the need for a critical reevaluation of the literature in light of emerging evidence of the chronic nature of these adverse drug effects.
Literature
1.
go back to reference Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2163–96.PubMedCrossRef Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2163–96.PubMedCrossRef
2.
go back to reference Pollach G. Neurotoxicity of quinoline-related anti-infectives: an underestimated burden of the health care systems in Africa? Gesundheitsökonomie Qual. 2013;19:109–13 (in German).CrossRef Pollach G. Neurotoxicity of quinoline-related anti-infectives: an underestimated burden of the health care systems in Africa? Gesundheitsökonomie Qual. 2013;19:109–13 (in German).CrossRef
3.
go back to reference Weiss MG. The interrelationship of tropical disease and mental disorder: conceptual framework and literature review (Part I-malaria). Cult Med Psychiatry. 1985;9:121–200.PubMedCrossRef Weiss MG. The interrelationship of tropical disease and mental disorder: conceptual framework and literature review (Part I-malaria). Cult Med Psychiatry. 1985;9:121–200.PubMedCrossRef
4.
go back to reference Arieti S. Histopathologic changes in cerebral malaria and their relation to psychotic sequels. Arch Neurol Psychiatry. 1946;56:79–104.PubMedCrossRef Arieti S. Histopathologic changes in cerebral malaria and their relation to psychotic sequels. Arch Neurol Psychiatry. 1946;56:79–104.PubMedCrossRef
5.
go back to reference Anderson WK. Malaria in history. In: Malarial psychoses and neuroses. London: Oxford University Press; 1927. p. 9–16. Anderson WK. Malaria in history. In: Malarial psychoses and neuroses. London: Oxford University Press; 1927. p. 9–16.
7.
go back to reference Chavigny M. Nervous and mental complications of malaria. Encephale. 1912;7:387–91 (in French). Chavigny M. Nervous and mental complications of malaria. Encephale. 1912;7:387–91 (in French).
8.
go back to reference Carlill H. Korsakow’s psychosis in association with malaria. Lancet. 1917;189:648–50.CrossRef Carlill H. Korsakow’s psychosis in association with malaria. Lancet. 1917;189:648–50.CrossRef
10.
go back to reference Pope C. Chronic malarial cachexia and its relation to neurasthenoid conditions. Boston Med Surg J. 1914;170:193–7.CrossRef Pope C. Chronic malarial cachexia and its relation to neurasthenoid conditions. Boston Med Surg J. 1914;170:193–7.CrossRef
11.
go back to reference Papastratigakis G. Mental confusion from malaria. Encephale. 1922;17:105–9 (in French). Papastratigakis G. Mental confusion from malaria. Encephale. 1922;17:105–9 (in French).
12.
go back to reference Turner C. The neurologic and psychiatric manifestations of malaria. South Med J. 1936;29:578–86.CrossRef Turner C. The neurologic and psychiatric manifestations of malaria. South Med J. 1936;29:578–86.CrossRef
13.
go back to reference Masson CB. The effect of malaria on the nervous system with special reference to the malarial psychoses. Am J Med Sci. 1924;168:334–71.CrossRef Masson CB. The effect of malaria on the nervous system with special reference to the malarial psychoses. Am J Med Sci. 1924;168:334–71.CrossRef
14.
go back to reference Review Book. Malarial psychoses and neuroses; their medical, sociological and legal aspects. J Neurol Psychopathol. 1927;8:84–5. Review Book. Malarial psychoses and neuroses; their medical, sociological and legal aspects. J Neurol Psychopathol. 1927;8:84–5.
15.
go back to reference Anderson WK. Malarial psychoses and neuroses. London: Oxford University Press; 1927. p. i–vii. Anderson WK. Malarial psychoses and neuroses. London: Oxford University Press; 1927. p. i–vii.
16.
go back to reference Arbuse DI. Neuropsychiatric manifestations in malaria. US Nav Med Bull. 1945;45:304–9. Arbuse DI. Neuropsychiatric manifestations in malaria. US Nav Med Bull. 1945;45:304–9.
17.
go back to reference Boshes B. Neuropsychiatric manifestations during the course of malaria. Arch Neurol Psychiatry. 1947;58:14–27.PubMedCrossRef Boshes B. Neuropsychiatric manifestations during the course of malaria. Arch Neurol Psychiatry. 1947;58:14–27.PubMedCrossRef
18.
go back to reference Journal of the Royal Army Medical Corps. Editorial. Psychiatry. J R Army Med Corps. 1945;84:81–2. Journal of the Royal Army Medical Corps. Editorial. Psychiatry. J R Army Med Corps. 1945;84:81–2.
20.
go back to reference Blocker W, Kastl AJ, Daroff RB. The psychiatric manifestations of cerebral malaria. Am J Psychiatry. 1968;125:192–6.CrossRef Blocker W, Kastl AJ, Daroff RB. The psychiatric manifestations of cerebral malaria. Am J Psychiatry. 1968;125:192–6.CrossRef
22.
go back to reference Kastl AJ, Daroff RB, Blocker WW. Psychological testing of cerebral malaria patients. J Nerv Ment Dis. 1968;147:553–61.PubMedCrossRef Kastl AJ, Daroff RB, Blocker WW. Psychological testing of cerebral malaria patients. J Nerv Ment Dis. 1968;147:553–61.PubMedCrossRef
23.
go back to reference Varney NR, Roberts RJ, Springer JA, Connell SK, Wood PS. Neuropsychiatric sequelae of cerebral malaria in Vietnam veterans. J Nerv Ment Dis. 1997;185:695–703.PubMedCrossRef Varney NR, Roberts RJ, Springer JA, Connell SK, Wood PS. Neuropsychiatric sequelae of cerebral malaria in Vietnam veterans. J Nerv Ment Dis. 1997;185:695–703.PubMedCrossRef
24.
go back to reference Richardson ED, Varney NR, Roberts RJ, Springer JA, Wood PS. Long-term cognitive sequelae of cerebral malaria in Vietnam veterans. Appl Neuropsychol. 1997;4:238–43.PubMedCrossRef Richardson ED, Varney NR, Roberts RJ, Springer JA, Wood PS. Long-term cognitive sequelae of cerebral malaria in Vietnam veterans. Appl Neuropsychol. 1997;4:238–43.PubMedCrossRef
25.
go back to reference Fernando SD, de Silva D, Wickremasinghe R. Short-term impact of an acute attack of malaria on the cognitive performance of schoolchildren living in a malaria-endemic area of Sri Lanka. Trans R Soc Trop Med Hyg. 2003;97:633–9.PubMedCrossRef Fernando SD, de Silva D, Wickremasinghe R. Short-term impact of an acute attack of malaria on the cognitive performance of schoolchildren living in a malaria-endemic area of Sri Lanka. Trans R Soc Trop Med Hyg. 2003;97:633–9.PubMedCrossRef
26.
go back to reference Fernando SD, Gunawardena DM, Bandara MRSS, De Silva D, Carter R, Mendis KN, et al. The impact of repeated malaria attacks on the school performance of children. Am J Trop Med Hyg. 2003;69:582–8.PubMed Fernando SD, Gunawardena DM, Bandara MRSS, De Silva D, Carter R, Mendis KN, et al. The impact of repeated malaria attacks on the school performance of children. Am J Trop Med Hyg. 2003;69:582–8.PubMed
28.
go back to reference Gay F, Zougbédé S, N’Dilimabaka N, Rebollo A, Mazier D, Moreno A. Cerebral malaria: What is known and what is being researched. Rev Neurol (Paris). 2012;168:239–56.CrossRef Gay F, Zougbédé S, N’Dilimabaka N, Rebollo A, Mazier D, Moreno A. Cerebral malaria: What is known and what is being researched. Rev Neurol (Paris). 2012;168:239–56.CrossRef
29.
go back to reference de Miranda AS, Brant F, Machado FS, Rachid MA, Teixeira AL. Improving cognitive outcome in cerebral malaria: insights from clinical and experimental research. Cent Nerv Syst Agents Med Chem. 2011;11:285–95.PubMedCrossRef de Miranda AS, Brant F, Machado FS, Rachid MA, Teixeira AL. Improving cognitive outcome in cerebral malaria: insights from clinical and experimental research. Cent Nerv Syst Agents Med Chem. 2011;11:285–95.PubMedCrossRef
30.
go back to reference Kihara M, Carter JA, Newton CRJC. The effect of Plasmodium falciparum on cognition: a systematic review. Trop Med Int Heal. 2006;11:386–97.CrossRef Kihara M, Carter JA, Newton CRJC. The effect of Plasmodium falciparum on cognition: a systematic review. Trop Med Int Heal. 2006;11:386–97.CrossRef
31.
go back to reference Dugbartey AT, Dugbartey MT, Apedo MY. Delayed neuropsychiatric effects of malaria in Ghana. J Nerv Ment Dis. 1998;186:183–6.PubMedCrossRef Dugbartey AT, Dugbartey MT, Apedo MY. Delayed neuropsychiatric effects of malaria in Ghana. J Nerv Ment Dis. 1998;186:183–6.PubMedCrossRef
32.
go back to reference Kariuki SM, Abubakar A, Newton CR, Kihara M. Impairment of executive function in Kenyan children exposed to severe falciparum malaria with neurological involvement. Malar J. 2014;13:365.PubMedPubMedCentralCrossRef Kariuki SM, Abubakar A, Newton CR, Kihara M. Impairment of executive function in Kenyan children exposed to severe falciparum malaria with neurological involvement. Malar J. 2014;13:365.PubMedPubMedCentralCrossRef
34.
35.
go back to reference Marsden PD, Bruce-Chwatt LJ. Cerebral malaria. In: Hornabrook R, editor. Topics on tropical neurology. Philadelphia: F.A. Davis Company; 1975. p. 29–44. Marsden PD, Bruce-Chwatt LJ. Cerebral malaria. In: Hornabrook R, editor. Topics on tropical neurology. Philadelphia: F.A. Davis Company; 1975. p. 29–44.
37.
go back to reference Idro R, Jenkins NE, Newton CRJC. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol. 2005;4:827–40.PubMedCrossRef Idro R, Jenkins NE, Newton CRJC. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol. 2005;4:827–40.PubMedCrossRef
38.
go back to reference WHO. Guidelines for the treatment of malaria. 3rd ed. Geneva: World Health Organization; 2014. WHO. Guidelines for the treatment of malaria. 3rd ed. Geneva: World Health Organization; 2014.
40.
go back to reference Boivin MJ, Vokhiwa M, Sikorskii A, Magen JG, Beare NAV. Cerebral malaria retinopathy predictors of persisting neurocognitive outcomes in Malawian children. Pediatr Infect Dis J. 2014;33:821–4.PubMedPubMedCentralCrossRef Boivin MJ, Vokhiwa M, Sikorskii A, Magen JG, Beare NAV. Cerebral malaria retinopathy predictors of persisting neurocognitive outcomes in Malawian children. Pediatr Infect Dis J. 2014;33:821–4.PubMedPubMedCentralCrossRef
42.
go back to reference Osuntokun BO. Malaria and the nervous system. Afr J Med Med Sci. 1983;12:165–72.PubMed Osuntokun BO. Malaria and the nervous system. Afr J Med Med Sci. 1983;12:165–72.PubMed
44.
go back to reference Garg RK, Karak B, Misra S. Neurological manifestations of malaria: an update. Neurol India. 1999;47:85–91.PubMed Garg RK, Karak B, Misra S. Neurological manifestations of malaria: an update. Neurol India. 1999;47:85–91.PubMed
45.
go back to reference Boivin MJ, Bangirana P, Byarugaba J, Opoka RO, Idro R, Jurek AM, et al. Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics. 2007;119:e360–6.PubMedPubMedCentralCrossRef Boivin MJ, Bangirana P, Byarugaba J, Opoka RO, Idro R, Jurek AM, et al. Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics. 2007;119:e360–6.PubMedPubMedCentralCrossRef
46.
go back to reference John CC, Bangirana P, Byarugaba J, Opoka RO, Idro R, Jurek AM, et al. Cerebral malaria in children is associated with long-term cognitive impairment. Pediatrics. 2008;122:e92–9.PubMedPubMedCentralCrossRef John CC, Bangirana P, Byarugaba J, Opoka RO, Idro R, Jurek AM, et al. Cerebral malaria in children is associated with long-term cognitive impairment. Pediatrics. 2008;122:e92–9.PubMedPubMedCentralCrossRef
47.
go back to reference Bangirana P, Musisi S, Boivin MJ, Ehnvall A, John CC, Bergemann TL, et al. Malaria with neurological involvement in Ugandan children: effect on cognitive ability, academic achievement and behaviour. Malar J. 2011;10:334.PubMedPubMedCentralCrossRef Bangirana P, Musisi S, Boivin MJ, Ehnvall A, John CC, Bergemann TL, et al. Malaria with neurological involvement in Ugandan children: effect on cognitive ability, academic achievement and behaviour. Malar J. 2011;10:334.PubMedPubMedCentralCrossRef
48.
go back to reference Holding PA, Stevenson J, Peshu N, Marsh K. Cognitive sequelae of severe malaria with impaired consciousness. Trans R Soc Trop Med Hyg. 1999;93:529–34.PubMedCrossRef Holding PA, Stevenson J, Peshu N, Marsh K. Cognitive sequelae of severe malaria with impaired consciousness. Trans R Soc Trop Med Hyg. 1999;93:529–34.PubMedCrossRef
49.
go back to reference Carter JA, Mung’ala-Odera V, Neville BGR, Murira G, Mturi N, Musumba C, et al. Persistent neurocognitive impairments associated with severe falciparum malaria in Kenyan children. J Neurol Neurosurg Psychiatry. 2005;76:476–81.PubMedPubMedCentralCrossRef Carter JA, Mung’ala-Odera V, Neville BGR, Murira G, Mturi N, Musumba C, et al. Persistent neurocognitive impairments associated with severe falciparum malaria in Kenyan children. J Neurol Neurosurg Psychiatry. 2005;76:476–81.PubMedPubMedCentralCrossRef
50.
go back to reference Carter JA, Ross AJ, Neville BGR, Obiero E, Katana K, Mung’ala-Odera V, et al. Developmental impairments following severe falciparum malaria in children. Trop Med Int Health. 2005;10:3–10.PubMedCrossRef Carter JA, Ross AJ, Neville BGR, Obiero E, Katana K, Mung’ala-Odera V, et al. Developmental impairments following severe falciparum malaria in children. Trop Med Int Health. 2005;10:3–10.PubMedCrossRef
52.
go back to reference Idro R, Carter JA, Fegan G, Neville BGR, Newton CRJC. Risk factors for persisting neurological and cognitive impairments following cerebral malaria. Arch Dis Child. 2006;91:142–8.PubMedCrossRef Idro R, Carter JA, Fegan G, Neville BGR, Newton CRJC. Risk factors for persisting neurological and cognitive impairments following cerebral malaria. Arch Dis Child. 2006;91:142–8.PubMedCrossRef
53.
go back to reference Peixoto B, Kalei I. Neurocognitive sequelae of cerebral malaria in adults: a pilot study in Benguela Central Hospital, Angola. Asian Pac J Trop Biomed. 2013;3:532–5.PubMedPubMedCentralCrossRef Peixoto B, Kalei I. Neurocognitive sequelae of cerebral malaria in adults: a pilot study in Benguela Central Hospital, Angola. Asian Pac J Trop Biomed. 2013;3:532–5.PubMedPubMedCentralCrossRef
54.
go back to reference Bangirana P, Opoka RO, Boivin MJ, Idro R, Hodges JS, Romero RA, et al. Severe malarial anemia is associated with longterm neurocognitive impairment. Clin Infect Dis. 2014;59:336–44.PubMedPubMedCentralCrossRef Bangirana P, Opoka RO, Boivin MJ, Idro R, Hodges JS, Romero RA, et al. Severe malarial anemia is associated with longterm neurocognitive impairment. Clin Infect Dis. 2014;59:336–44.PubMedPubMedCentralCrossRef
56.
go back to reference de Silva HJ, Gamage R, Herath HK, Abeysekera DT, Peiris JB. A delayed onset cerebellar syndrome complicating falciparum malaria. Ceylon Med J. 1986;31:147–50.PubMed de Silva HJ, Gamage R, Herath HK, Abeysekera DT, Peiris JB. A delayed onset cerebellar syndrome complicating falciparum malaria. Ceylon Med J. 1986;31:147–50.PubMed
57.
go back to reference Senanayake N, de Silva HJ. Delayed cerebellar ataxia complicating falciparum malaria: a clinical study of 74 patients. J Neurol. 1994;241:456–9.PubMedCrossRef Senanayake N, de Silva HJ. Delayed cerebellar ataxia complicating falciparum malaria: a clinical study of 74 patients. J Neurol. 1994;241:456–9.PubMedCrossRef
58.
go back to reference Nguyen TH, Day NP, Ly VC, Waller D, Mai NT, Bethell DB, et al. Post-malaria neurological syndrome. Lancet. 1996;348:917–21.PubMedCrossRef Nguyen TH, Day NP, Ly VC, Waller D, Mai NT, Bethell DB, et al. Post-malaria neurological syndrome. Lancet. 1996;348:917–21.PubMedCrossRef
60.
go back to reference Sakaria A, Mahajan S, Desai R, Shah K. Delayed cerebellar ataxia: a rare self limiting complication of Plasmodium falciparum malaria. Adv Biomed Res. 2013;2:27.PubMedPubMedCentralCrossRef Sakaria A, Mahajan S, Desai R, Shah K. Delayed cerebellar ataxia: a rare self limiting complication of Plasmodium falciparum malaria. Adv Biomed Res. 2013;2:27.PubMedPubMedCentralCrossRef
61.
go back to reference Duque V, Seixas D, Ventura C, da Cunha S, Meliço-Silvestre A. Plasmodium falciparum malaria, bilateral sixth cranial nerve palsy and delayed cerebellar ataxia. J Infect Dev Ctries. 2012;6:290–4.PubMed Duque V, Seixas D, Ventura C, da Cunha S, Meliço-Silvestre A. Plasmodium falciparum malaria, bilateral sixth cranial nerve palsy and delayed cerebellar ataxia. J Infect Dev Ctries. 2012;6:290–4.PubMed
62.
go back to reference Rachita S, Satyasundar M, Mrutunjaya D, Birakishore R. Acute disseminated encephalomyelitis (ADEM)—a rare complication of falciparum malaria. Indian J Pediatr. 2012;80:499–501.PubMedCrossRef Rachita S, Satyasundar M, Mrutunjaya D, Birakishore R. Acute disseminated encephalomyelitis (ADEM)—a rare complication of falciparum malaria. Indian J Pediatr. 2012;80:499–501.PubMedCrossRef
63.
go back to reference Agrawal A, Goyal S. Acute demyelinating encephalomyelitis in a child following malaria. Indian Pediatr. 2012;49:922–3.PubMedCrossRef Agrawal A, Goyal S. Acute demyelinating encephalomyelitis in a child following malaria. Indian Pediatr. 2012;49:922–3.PubMedCrossRef
64.
go back to reference Koibuchi T, Nakamura T, Miura T, Endo T, Nakamura H, Takahashi T, Kim HS, et al. Acute disseminated encephalomyelitis following Plasmodium vivax malaria. J Infect Chemother. 2003;9:254–6.PubMedCrossRef Koibuchi T, Nakamura T, Miura T, Endo T, Nakamura H, Takahashi T, Kim HS, et al. Acute disseminated encephalomyelitis following Plasmodium vivax malaria. J Infect Chemother. 2003;9:254–6.PubMedCrossRef
65.
go back to reference Mohsen AH, McKendrick MW, Schmid ML, Green ST, Hadjivassiliou M, Romanowski C. Postmalaria neurological syndrome: a case of acute disseminated encephalomyelitis? J Neurol Neurosurg Psychiatry. 2000;68:388–9.PubMedPubMedCentralCrossRef Mohsen AH, McKendrick MW, Schmid ML, Green ST, Hadjivassiliou M, Romanowski C. Postmalaria neurological syndrome: a case of acute disseminated encephalomyelitis? J Neurol Neurosurg Psychiatry. 2000;68:388–9.PubMedPubMedCentralCrossRef
66.
go back to reference van der Wal G, Verhagen WIM, Dofferhoff ASM. Neurological complications following Plasmodium falciparum infection. Neth J Med. 2005;63:180–3.PubMed van der Wal G, Verhagen WIM, Dofferhoff ASM. Neurological complications following Plasmodium falciparum infection. Neth J Med. 2005;63:180–3.PubMed
67.
go back to reference Zambito Marsala S, Ferracci F, Cecotti L, Gentile M, Conte F, Candeago RM, et al. Post-malaria neurological syndrome: clinical and laboratory findings in one patient. Neurol Sci. 2006;27:442–4.PubMedCrossRef Zambito Marsala S, Ferracci F, Cecotti L, Gentile M, Conte F, Candeago RM, et al. Post-malaria neurological syndrome: clinical and laboratory findings in one patient. Neurol Sci. 2006;27:442–4.PubMedCrossRef
68.
go back to reference Markley JD, Edmond MB. Post-malaria neurological syndrome: a case report and review of the literature. J Travel Med. 2009;16:424–30.PubMedCrossRef Markley JD, Edmond MB. Post-malaria neurological syndrome: a case report and review of the literature. J Travel Med. 2009;16:424–30.PubMedCrossRef
69.
go back to reference Rakotoarivelo RA, Razafimahefa SH, Andrianasolo R, Fandresena FH, Razanamparany MMO, Randria MJD, et al. Post-malaria neurological syndrome complicating a Plasmodium falciparum malaria in Madagascar. Bull Soc Pathol Exot. 2012;105:199–201 (in French).PubMedCrossRef Rakotoarivelo RA, Razafimahefa SH, Andrianasolo R, Fandresena FH, Razanamparany MMO, Randria MJD, et al. Post-malaria neurological syndrome complicating a Plasmodium falciparum malaria in Madagascar. Bull Soc Pathol Exot. 2012;105:199–201 (in French).PubMedCrossRef
70.
go back to reference Prendki V, Elzière C, Durand R, Hamdi A, Cohen Y, Onnen I, et al. Post-malaria neurological syndrome—two cases in patients of African origin. Am J Trop Med Hyg. 2008;78:699–701.PubMed Prendki V, Elzière C, Durand R, Hamdi A, Cohen Y, Onnen I, et al. Post-malaria neurological syndrome—two cases in patients of African origin. Am J Trop Med Hyg. 2008;78:699–701.PubMed
71.
go back to reference Mizuno Y, Kato Y, Kanagawa S, Kudo K, Hashimoto M, Kunimoto M, et al. A case of postmalaria neurological syndrome in Japan. J Infect Chemother. 2006;12:399–401.PubMedCrossRef Mizuno Y, Kato Y, Kanagawa S, Kudo K, Hashimoto M, Kunimoto M, et al. A case of postmalaria neurological syndrome in Japan. J Infect Chemother. 2006;12:399–401.PubMedCrossRef
72.
go back to reference Freitas DRC, Santos JB, Castro CN. Healing with malaria: a brief historical review of malariotherapy for neurosyphilis, mental disorders and other infectious diseases. Rev Soc Bras Med Trop. 2014;47:260–1.PubMedCrossRef Freitas DRC, Santos JB, Castro CN. Healing with malaria: a brief historical review of malariotherapy for neurosyphilis, mental disorders and other infectious diseases. Rev Soc Bras Med Trop. 2014;47:260–1.PubMedCrossRef
73.
go back to reference British Medical Journal. Treatment of mental disease. Morison lectures, 1929. Br Med J. 1929;1:1135–36. British Medical Journal. Treatment of mental disease. Morison lectures, 1929. Br Med J. 1929;1:1135–36.
75.
go back to reference Wagner-Jauregg J. The treatment of general paresis by inoculation of malaria. J Nerv Ment Dis. 1922;55:369–75.CrossRef Wagner-Jauregg J. The treatment of general paresis by inoculation of malaria. J Nerv Ment Dis. 1922;55:369–75.CrossRef
76.
go back to reference The Scientific Monthly. Professor J. Von Wagner-Jauregg: Nobel Prize Winner, 1927. Sci Mon. 1927;26:190–2. The Scientific Monthly. Professor J. Von Wagner-Jauregg: Nobel Prize Winner, 1927. Sci Mon. 1927;26:190–2.
77.
go back to reference Howes OD, Khambhaita A, Fusar-Poli P. Julius Wagner-Jauregg, 1857–1940. Am J Psychiatry. 2009;166:409.PubMedCrossRef Howes OD, Khambhaita A, Fusar-Poli P. Julius Wagner-Jauregg, 1857–1940. Am J Psychiatry. 2009;166:409.PubMedCrossRef
79.
go back to reference Delgado HF. The treatment of paresis by inoculation with malaria. J Nerv Ment Dis. 1922;5:376–89. Delgado HF. The treatment of paresis by inoculation with malaria. J Nerv Ment Dis. 1922;5:376–89.
85.
go back to reference British Medical Journal. The first international malaria congress. BMJ. 1925;2:970–1. British Medical Journal. The first international malaria congress. BMJ. 1925;2:970–1.
87.
go back to reference British Medical Journal. Treatment of general paralysis by malaria. BMJ. 1923;1:908. British Medical Journal. Treatment of general paralysis by malaria. BMJ. 1923;1:908.
88.
go back to reference Yorke W. The malaria treatment of general paralysis. Nature. 1924;114:615–6.CrossRef Yorke W. The malaria treatment of general paralysis. Nature. 1924;114:615–6.CrossRef
89.
go back to reference The Science News-Letter. Prize method used here. Sci News Lett. 1927;12:393. The Science News-Letter. Prize method used here. Sci News Lett. 1927;12:393.
90.
go back to reference Worster-Drought C, Beccle HC. The treatment of general paralysis of the insane by pyrotherapy. BMJ. 1929;2:1256–7.CrossRef Worster-Drought C, Beccle HC. The treatment of general paralysis of the insane by pyrotherapy. BMJ. 1929;2:1256–7.CrossRef
92.
go back to reference Crawford CM. Treatment of paretic neurosyphilis by malaria and tryparsamide. Can J Public Health. 1940;31:99–105. Crawford CM. Treatment of paretic neurosyphilis by malaria and tryparsamide. Can J Public Health. 1940;31:99–105.
95.
go back to reference British Medical Journal. Malarial therapy and the community. BMJ. 1933;2:539. British Medical Journal. Malarial therapy and the community. BMJ. 1933;2:539.
96.
go back to reference British Medical Journal. Treatment of general paralysis by malaria. BMJ. 1924;1:289. British Medical Journal. Treatment of general paralysis by malaria. BMJ. 1924;1:289.
97.
go back to reference British Medical Journal. Treatment of general paralysis by malaria. BMJ. 1924;1:479. British Medical Journal. Treatment of general paralysis by malaria. BMJ. 1924;1:479.
98.
99.
go back to reference British Medical Journal. Therapeutic malaria. BMJ. 1927;2:831–2. British Medical Journal. Therapeutic malaria. BMJ. 1927;2:831–2.
100.
go back to reference Mayne B. The injection of mosquito sporozoites in malaria therapy. Public Health Rep. 1933;48:909–16.CrossRef Mayne B. The injection of mosquito sporozoites in malaria therapy. Public Health Rep. 1933;48:909–16.CrossRef
101.
go back to reference British Medical Journal. Malaria therapy. BMJ. 1938;2:796. British Medical Journal. Malaria therapy. BMJ. 1938;2:796.
102.
go back to reference Greenwood D. Conflicts of interest: the genesis of synthetic antimalarial agents in peace and war. J Antimicrob Chemother. 1995;36:857–72.PubMedCrossRef Greenwood D. Conflicts of interest: the genesis of synthetic antimalarial agents in peace and war. J Antimicrob Chemother. 1995;36:857–72.PubMedCrossRef
103.
go back to reference Dixon AWE, Ramsden W, Acton HW, Garrod AE, Hele TS, Nierenstein M, et al. Discussion on quinine and its related alkaloids in pharmacology and therapeutics. BMJ. 1920;2:113–21. Dixon AWE, Ramsden W, Acton HW, Garrod AE, Hele TS, Nierenstein M, et al. Discussion on quinine and its related alkaloids in pharmacology and therapeutics. BMJ. 1920;2:113–21.
104.
go back to reference Rieckmann KH, Powell RD, McNamara JV, Willerson D, Lass L, Frischer H, et al. Effects of tetracycline against chloroquine-resistant and chloroquine-sensitive Plasmodium falciparum. Am J Trop Med Hyg. 1971;20:811–5.PubMed Rieckmann KH, Powell RD, McNamara JV, Willerson D, Lass L, Frischer H, et al. Effects of tetracycline against chloroquine-resistant and chloroquine-sensitive Plasmodium falciparum. Am J Trop Med Hyg. 1971;20:811–5.PubMed
105.
go back to reference Clyde DF, Miller RM, DuPont HL, Hornick RB. Antimalarial effects of tetracyclines in man. J Trop Med Hyg. 1971;74:238–42.PubMed Clyde DF, Miller RM, DuPont HL, Hornick RB. Antimalarial effects of tetracyclines in man. J Trop Med Hyg. 1971;74:238–42.PubMed
106.
go back to reference Jiang JB, Li GQ, Guo XB, Kong YC, Arnold K. Antimalarial activity of mefloquine and qinghaosu. Lancet. 1982;2:285–8.PubMedCrossRef Jiang JB, Li GQ, Guo XB, Kong YC, Arnold K. Antimalarial activity of mefloquine and qinghaosu. Lancet. 1982;2:285–8.PubMedCrossRef
107.
go back to reference Arnold K. Qinghaosu and derivatives in the treatment of malaria—a personal review. J Hong Kong Med Assoc. 1993;45:189–96. Arnold K. Qinghaosu and derivatives in the treatment of malaria—a personal review. J Hong Kong Med Assoc. 1993;45:189–96.
109.
go back to reference Sullivan DJ. Cinchona Alkaloids: Quinine and Quinidine. In: Staines HM, Krishna S, editors. Treatment and prevention of malaria. Basel: Springer Basel; 2012. p. 45–68. Sullivan DJ. Cinchona Alkaloids: Quinine and Quinidine. In: Staines HM, Krishna S, editors. Treatment and prevention of malaria. Basel: Springer Basel; 2012. p. 45–68.
110.
go back to reference Kritzer JH. Quinine–cinchona. In: Haskel Kritzer J, editor. Text-book of iridiagnosis: guide in treatment. Chicago: J. Hazkel Kritzer. 1921. p. 81–8. Kritzer JH. Quinine–cinchona. In: Haskel Kritzer J, editor. Text-book of iridiagnosis: guide in treatment. Chicago: J. Hazkel Kritzer. 1921. p. 81–8.
111.
go back to reference Mishra KC. Delirium after quinine administration. Antiseptic. 1947;44:614.PubMed Mishra KC. Delirium after quinine administration. Antiseptic. 1947;44:614.PubMed
112.
go back to reference Prasad RS, Kodali VRR, Khuraijam GS, Cho M, Travers JP. Acute confusion and blindness from quinine toxicity. Eur J Emerg Med. 2003;10:353–6.PubMedCrossRef Prasad RS, Kodali VRR, Khuraijam GS, Cho M, Travers JP. Acute confusion and blindness from quinine toxicity. Eur J Emerg Med. 2003;10:353–6.PubMedCrossRef
113.
go back to reference Billig N, Buongiorno P. Quinidine-induced organic mental disorders. J Am Geriatr Soc. 1985;33:504–6.PubMedCrossRef Billig N, Buongiorno P. Quinidine-induced organic mental disorders. J Am Geriatr Soc. 1985;33:504–6.PubMedCrossRef
114.
116.
117.
go back to reference Johnson AG, Day RO, Seldon WA. A functional psychosis precipitated by quinidine. Med J Aust. 1990;153:47–9.PubMed Johnson AG, Day RO, Seldon WA. A functional psychosis precipitated by quinidine. Med J Aust. 1990;153:47–9.PubMed
119.
go back to reference von Oettingen W. Acridine dyes. In: The therapeutic agents of the quinoline group. New York: The Chemical Catalog Company; 1933. p. 239–55. von Oettingen W. Acridine dyes. In: The therapeutic agents of the quinoline group. New York: The Chemical Catalog Company; 1933. p. 239–55.
120.
go back to reference Russell PF. Plasmochin, plasmochin with quinine salts and atabrine in malaria therapy. Arch Intern Med. 1934;53:309–20.CrossRef Russell PF. Plasmochin, plasmochin with quinine salts and atabrine in malaria therapy. Arch Intern Med. 1934;53:309–20.CrossRef
121.
go back to reference British Medical Journal. Quinine and World War. Br Med J. 1942;1:152–3. British Medical Journal. Quinine and World War. Br Med J. 1942;1:152–3.
122.
go back to reference de Mello IF. Chemoprophylaxis of malaria in Portugese India. Suid-Afrikaanse Tydskr vir Geneeskd. 1938;12:710–24. de Mello IF. Chemoprophylaxis of malaria in Portugese India. Suid-Afrikaanse Tydskr vir Geneeskd. 1938;12:710–24.
123.
go back to reference Ad A, Needham DE. More observations on atebrin. Lancet. 1933;222:929–30. Ad A, Needham DE. More observations on atebrin. Lancet. 1933;222:929–30.
124.
go back to reference Kingsbury AN. Psychoses in cases of malaria following exhibition of atebrin. Lancet. 1934;224:979–82.CrossRef Kingsbury AN. Psychoses in cases of malaria following exhibition of atebrin. Lancet. 1934;224:979–82.CrossRef
125.
126.
go back to reference Winthrop Chemical Company. Malaria: chemotherapy with atabrine. New York: Winthrop Chemical Company; 1938. Winthrop Chemical Company. Malaria: chemotherapy with atabrine. New York: Winthrop Chemical Company; 1938.
127.
go back to reference The Science News-Letter. New anti-malarial drugs announced ahead of time. Sci News Lett. 1942;42:108. The Science News-Letter. New anti-malarial drugs announced ahead of time. Sci News Lett. 1942;42:108.
128.
go back to reference Baxter JP. Antimalarials. In: Scientists against time. Boston: Little, Brown and Company; 1946. p. 299–320. Baxter JP. Antimalarials. In: Scientists against time. Boston: Little, Brown and Company; 1946. p. 299–320.
129.
go back to reference Committee on Medical Research of the Office of Scientific Research and Development. Minutes of meeting of atabrine conference held at the national academy of sciences November 2, 1942. In: Bulletin of malaria research, vol 1. Washington, DC: Board for the Coordination of Malarial Studies; 1942. p. 46a–f. Committee on Medical Research of the Office of Scientific Research and Development. Minutes of meeting of atabrine conference held at the national academy of sciences November 2, 1942. In: Bulletin of malaria research, vol 1. Washington, DC: Board for the Coordination of Malarial Studies; 1942. p. 46a–f.
130.
go back to reference Clark WM. History of the co-operative wartime program. In: Wiselogle FY, editor. A survey of antimalarial drugs, 1941–1945, vol. 1. Ann Arbor: J.W. Edwards; 1946. p. 2–57. Clark WM. History of the co-operative wartime program. In: Wiselogle FY, editor. A survey of antimalarial drugs, 1941–1945, vol. 1. Ann Arbor: J.W. Edwards; 1946. p. 2–57.
131.
go back to reference Temkin O, Ramsey EM. Antimalarial drugs: summary of classified material on file. Washington, DC: National Research Council; 1944. Temkin O, Ramsey EM. Antimalarial drugs: summary of classified material on file. Washington, DC: National Research Council; 1944.
132.
go back to reference Loughlin EH, Bennett RH, Santora E, Mattucci S. Clinical toxicity of atabrine dihydrochloride. War Med. 1943;4:272–9. Loughlin EH, Bennett RH, Santora E, Mattucci S. Clinical toxicity of atabrine dihydrochloride. War Med. 1943;4:272–9.
133.
go back to reference Carden GA. Introduction. In: Malaria reports, vol 1. Washington, DC: Board for the Coordination of Malarial Studies; 1946. p. i–xx. Carden GA. Introduction. In: Malaria reports, vol 1. Washington, DC: Board for the Coordination of Malarial Studies; 1946. p. i–xx.
134.
go back to reference Newell HW, Lidz T. Malaria report #180: a clinical study of the toxicity of atabrine on the central nervous system. In: Reports Malaria, editor. Vol 2. Washington, DC: Board for the Coordination of Malarial Studies; 1944. p. 1–2. Newell HW, Lidz T. Malaria report #180: a clinical study of the toxicity of atabrine on the central nervous system. In: Reports Malaria, editor. Vol 2. Washington, DC: Board for the Coordination of Malarial Studies; 1944. p. 1–2.
135.
go back to reference Newell HW, Lidz T. The toxicity of atabrine to the central nervous system. Am J Psychiatry. 1946;102:805–18.PubMedCrossRef Newell HW, Lidz T. The toxicity of atabrine to the central nervous system. Am J Psychiatry. 1946;102:805–18.PubMedCrossRef
136.
go back to reference Sheppeck ML, Wexberg LE. Malaria Report #A-196: abstract of report on toxic psychoses associated with administration of atabrine from an overseas hospital. In: Malaria reports, vol 2. Washington, DC: Board for the Coordination of Malarial Studies; 1944. p. 1–2. Sheppeck ML, Wexberg LE. Malaria Report #A-196: abstract of report on toxic psychoses associated with administration of atabrine from an overseas hospital. In: Malaria reports, vol 2. Washington, DC: Board for the Coordination of Malarial Studies; 1944. p. 1–2.
137.
go back to reference Gaskill HS, Fitz-Hugh T. Toxic psychoses following atabrine. Bull US Army Med Dep. 1945;86:63–9. Gaskill HS, Fitz-Hugh T. Toxic psychoses following atabrine. Bull US Army Med Dep. 1945;86:63–9.
138.
go back to reference Lidz T, Kahn RL. Toxicity of quinacrine (atabrine) for the central nervous system; an experimental study on human subjects. Arch Neurol Psychiatry. 1946;56:284–99.PubMedCrossRef Lidz T, Kahn RL. Toxicity of quinacrine (atabrine) for the central nervous system; an experimental study on human subjects. Arch Neurol Psychiatry. 1946;56:284–99.PubMedCrossRef
139.
go back to reference US Army Medical Deparment. Malaria Report #181: experimental study of the toxicity of atabrine to the human central nervous system. In: Malaria reports, vol 2. Washington, DC: Board for the Coordination of Malarial Studies; 1944. p. 2–5. US Army Medical Deparment. Malaria Report #181: experimental study of the toxicity of atabrine to the human central nervous system. In: Malaria reports, vol 2. Washington, DC: Board for the Coordination of Malarial Studies; 1944. p. 2–5.
140.
go back to reference Engel GL, Romano J, Ferris EB. Effect of quinacrine (atabrine) on the central nervous system; clinical and electroencephalographic studies. Arch Neurol Psychiatry. 1947;58:337–50.PubMedCrossRef Engel GL, Romano J, Ferris EB. Effect of quinacrine (atabrine) on the central nervous system; clinical and electroencephalographic studies. Arch Neurol Psychiatry. 1947;58:337–50.PubMedCrossRef
141.
go back to reference Engel GL, Romeno J, Ferris EB, Schmidt LH. Malaria report #212: the effect of atabrine on the central nervous system. In: Malaria reports, vol 2. Washington, DC: Board for the Coordination of Malarial Studies; 1944. p. 1–4. Engel GL, Romeno J, Ferris EB, Schmidt LH. Malaria report #212: the effect of atabrine on the central nervous system. In: Malaria reports, vol 2. Washington, DC: Board for the Coordination of Malarial Studies; 1944. p. 1–4.
142.
go back to reference Engel GL, Romano J, Ferris EB. Malaria report #266: the effect of atabrine on the central nervous system. In: Malaria reports, vol 3. Washington, DC: Board for the Coordination of Malarial Studies; 1944. p. 1–4. Engel GL, Romano J, Ferris EB. Malaria report #266: the effect of atabrine on the central nervous system. In: Malaria reports, vol 3. Washington, DC: Board for the Coordination of Malarial Studies; 1944. p. 1–4.
143.
go back to reference Lull GF. Reactions attributed to atabrine. J Mil Med Pac. 1945;1:1–4. Lull GF. Reactions attributed to atabrine. J Mil Med Pac. 1945;1:1–4.
144.
go back to reference McIntire RT. Treatment of clinical malaria. Navy Dep BUMED News Lett. 1944;4:17–25. McIntire RT. Treatment of clinical malaria. Navy Dep BUMED News Lett. 1944;4:17–25.
145.
go back to reference Peal S. Psychiatric experiences in a tropical theater of operations. Bull US Army Med Dep. 1944;73:68–78. Peal S. Psychiatric experiences in a tropical theater of operations. Bull US Army Med Dep. 1944;73:68–78.
146.
go back to reference Greiber MF. Psychoses associated with the administration of atabrine. Am J Psychiatry. 1947;104:306–14.PubMedCrossRef Greiber MF. Psychoses associated with the administration of atabrine. Am J Psychiatry. 1947;104:306–14.PubMedCrossRef
148.
go back to reference Mergener JC. Psychosis following administration of quinacrine hydrochloride for malaria; neuropsychiatric study of a case. War Med. 1945;8:250–2.PubMed Mergener JC. Psychosis following administration of quinacrine hydrochloride for malaria; neuropsychiatric study of a case. War Med. 1945;8:250–2.PubMed
149.
go back to reference Sheppeck ML, Wexberg LE. Toxic psychoses associated with administration of quinacrine. Arch Neurol Psychiatry. 1946;55:489–510.PubMedCrossRef Sheppeck ML, Wexberg LE. Toxic psychoses associated with administration of quinacrine. Arch Neurol Psychiatry. 1946;55:489–510.PubMedCrossRef
151.
go back to reference Kapur KB, Das Gupta PR. Sexual disorder in “mepacrine psychoses”. Indian Med Gaz. 1950;85:20–2. Kapur KB, Das Gupta PR. Sexual disorder in “mepacrine psychoses”. Indian Med Gaz. 1950;85:20–2.
152.
go back to reference Hoobler SW. Psychotic reactions to the ingestion of large doses of quinacrine in normal subjects. Am J Trop Med Hyg. 1947;27:477–81. Hoobler SW. Psychotic reactions to the ingestion of large doses of quinacrine in normal subjects. Am J Trop Med Hyg. 1947;27:477–81.
153.
go back to reference Coatney GR. Pitfalls in a discovery: the chronicle of chloroquine. Am J Trop Med Hyg. 1963;12:121–8.PubMed Coatney GR. Pitfalls in a discovery: the chronicle of chloroquine. Am J Trop Med Hyg. 1963;12:121–8.PubMed
154.
go back to reference Pou S, Winter RW, Nilsen A, Kelly JX, Li Y, Doggett JS, et al. Sontochin as a guide to the development of drugs against chloroquine-resistant malaria. Antimicrob Agents Chemother. 2012;56:3475–80.PubMedPubMedCentralCrossRef Pou S, Winter RW, Nilsen A, Kelly JX, Li Y, Doggett JS, et al. Sontochin as a guide to the development of drugs against chloroquine-resistant malaria. Antimicrob Agents Chemother. 2012;56:3475–80.PubMedPubMedCentralCrossRef
155.
go back to reference Southworth H. C.I.O.S. target number 24/3 medical. In: Farben IG, editor. Clinical testing of antimalarials. London: His Majesty’s Stationery Office; 1945. Southworth H. C.I.O.S. target number 24/3 medical. In: Farben IG, editor. Clinical testing of antimalarials. London: His Majesty’s Stationery Office; 1945.
156.
go back to reference Berliner R, Butler T. Summary of data on the drugs tested in man. In: Wiselogle FY, editor. A survey of antimalarial drugs, 1941–1945, vol. 1. Ann Arbor: J.W. Edwards; 1946. p. 221–451. Berliner R, Butler T. Summary of data on the drugs tested in man. In: Wiselogle FY, editor. A survey of antimalarial drugs, 1941–1945, vol. 1. Ann Arbor: J.W. Edwards; 1946. p. 221–451.
157.
go back to reference Ruhe DS, Cooper WC. Studies in human malaria; the protective and therapeutic action of SN 6911 against St. Elizabeth strain vivax malaria. Am J Hyg. 1949;49:41–8.PubMed Ruhe DS, Cooper WC. Studies in human malaria; the protective and therapeutic action of SN 6911 against St. Elizabeth strain vivax malaria. Am J Hyg. 1949;49:41–8.PubMed
158.
go back to reference Board for the Coordination of Malarial Studies. Minutes of the meeting of the board for the coordination of malarial studies 25 July 1945. In: Bulletin of malaria research, vol 2. Washington, DC: Board for the Coordination of Malarial Studies; 1945. p. 1259–63. Board for the Coordination of Malarial Studies. Minutes of the meeting of the board for the coordination of malarial studies 25 July 1945. In: Bulletin of malaria research, vol 2. Washington, DC: Board for the Coordination of Malarial Studies; 1945. p. 1259–63.
159.
go back to reference The Science News-Letter. Better antimalarial drug. Sci News Lett. 1946;49:30–1. The Science News-Letter. Better antimalarial drug. Sci News Lett. 1946;49:30–1.
160.
161.
go back to reference Malaria Subcommittee of the Colonial Medical Research Committee. Use of antimalarial drugs. recommendations on the use of antimalarial drugs. BMJ. 1954;2:148–50.CrossRef Malaria Subcommittee of the Colonial Medical Research Committee. Use of antimalarial drugs. recommendations on the use of antimalarial drugs. BMJ. 1954;2:148–50.CrossRef
163.
go back to reference Reis J. Insomnia induced by chloroquine in the treatment of lupus erythematosus disseminatus. Presse Médicale. 1991;20:659 (in French). Reis J. Insomnia induced by chloroquine in the treatment of lupus erythematosus disseminatus. Presse Médicale. 1991;20:659 (in French).
164.
go back to reference Bhatia MS. Chloroquine—induced recurrent psychosis (brief report). Indian J Med Sci. 1996;50:302–4.PubMed Bhatia MS. Chloroquine—induced recurrent psychosis (brief report). Indian J Med Sci. 1996;50:302–4.PubMed
165.
go back to reference Maxwell NM, Nevin RL, Stahl S, Block J, Shugarts S, Wu AHB, et al. Prolonged neuropsychiatric effects following management of chloroquine intoxication with psychotropic polypharmacy. Clin Case Rep. 2015;3:379–87.PubMedPubMedCentralCrossRef Maxwell NM, Nevin RL, Stahl S, Block J, Shugarts S, Wu AHB, et al. Prolonged neuropsychiatric effects following management of chloroquine intoxication with psychotropic polypharmacy. Clin Case Rep. 2015;3:379–87.PubMedPubMedCentralCrossRef
167.
169.
go back to reference Bhatia MS, Dhar NK, Singhal PK. Capgras’ syndrome in chloroquine induced psychosis. Indian Pediatr. 1988;25:905–6.PubMed Bhatia MS, Dhar NK, Singhal PK. Capgras’ syndrome in chloroquine induced psychosis. Indian Pediatr. 1988;25:905–6.PubMed
170.
go back to reference Bhatia MS, Singhal PK, Agrawal P, Malik SC. Capgras syndrome in chloroquine induced psychosis. Indian J Psychiatry. 1988;30:311–3.PubMedPubMedCentral Bhatia MS, Singhal PK, Agrawal P, Malik SC. Capgras syndrome in chloroquine induced psychosis. Indian J Psychiatry. 1988;30:311–3.PubMedPubMedCentral
172.
go back to reference Mustakallio KK, Pihkanen TA, Putkonen T. Toxic psychosis during chloroquine treatment. Ann Med Intern Fenn. 1962;51:223–8.PubMed Mustakallio KK, Pihkanen TA, Putkonen T. Toxic psychosis during chloroquine treatment. Ann Med Intern Fenn. 1962;51:223–8.PubMed
173.
go back to reference Bogaczewicz J, Sobow T, Bogaczewicz A, Robak E, Bienkowski P, Sysa-Jedrzejowska A, et al. Exacerbations of bipolar disorder triggered by chloroquine in systemic lupus erythematosus—a case report. Lupus. 2014;23:188–93.PubMedCrossRef Bogaczewicz J, Sobow T, Bogaczewicz A, Robak E, Bienkowski P, Sysa-Jedrzejowska A, et al. Exacerbations of bipolar disorder triggered by chloroquine in systemic lupus erythematosus—a case report. Lupus. 2014;23:188–93.PubMedCrossRef
174.
go back to reference Good MI, Shader RI. Behavioral toxicity and equivocal suicide associated with chloroquine and its derivatives. Am J Psychiatry. 1977;134:798–801.PubMedCrossRef Good MI, Shader RI. Behavioral toxicity and equivocal suicide associated with chloroquine and its derivatives. Am J Psychiatry. 1977;134:798–801.PubMedCrossRef
175.
go back to reference Good MI, Shader RI. Lethality and behavioral side effects of chloroquine. J Clin Psychopharmacol. 1982;2:40–7.PubMedCrossRef Good MI, Shader RI. Lethality and behavioral side effects of chloroquine. J Clin Psychopharmacol. 1982;2:40–7.PubMedCrossRef
176.
go back to reference Jousset N, Rougé-Maillart C, Turcant A, Guilleux M, Le Bouil A, Tracqui A. Suicide by skull stab wounds: a case of drug-induced psychosis. Am J Forensic Med Pathol. 2010;31:378–81.PubMedCrossRef Jousset N, Rougé-Maillart C, Turcant A, Guilleux M, Le Bouil A, Tracqui A. Suicide by skull stab wounds: a case of drug-induced psychosis. Am J Forensic Med Pathol. 2010;31:378–81.PubMedCrossRef
177.
go back to reference Burrell ZL, Martinez AC. Chloroquine and hydroxychloroquine in the treatment of cardiac arrhythmias. N Engl J Med. 1958;258:798–800.PubMedCrossRef Burrell ZL, Martinez AC. Chloroquine and hydroxychloroquine in the treatment of cardiac arrhythmias. N Engl J Med. 1958;258:798–800.PubMedCrossRef
178.
179.
go back to reference Ragan E, Wilson R, Li F, Spasoff R, Bigelow G, Spinner N. Psychotic symptoms in volunteers serving overseas. Lancet. 1985;2:37.PubMedCrossRef Ragan E, Wilson R, Li F, Spasoff R, Bigelow G, Spinner N. Psychotic symptoms in volunteers serving overseas. Lancet. 1985;2:37.PubMedCrossRef
180.
go back to reference Biswas PS, Sen D, Majumdar R. Psychosis following chloroquine ingestion: a 10-year comparative study from a malaria-hyperendemic district of India. Gen Hosp Psychiatry. 2014;36:181–6.PubMedCrossRef Biswas PS, Sen D, Majumdar R. Psychosis following chloroquine ingestion: a 10-year comparative study from a malaria-hyperendemic district of India. Gen Hosp Psychiatry. 2014;36:181–6.PubMedCrossRef
181.
go back to reference Telgt DS, van der Ven AJ, Schimmer B, Droogleever-Fortuyn HA, Sauerwein RW. Serious psychiatric symptoms after chloroquine treatment following experimental malaria infection. Ann Pharmacother. 2005;39:551–4.PubMedCrossRef Telgt DS, van der Ven AJ, Schimmer B, Droogleever-Fortuyn HA, Sauerwein RW. Serious psychiatric symptoms after chloroquine treatment following experimental malaria infection. Ann Pharmacother. 2005;39:551–4.PubMedCrossRef
183.
184.
185.
go back to reference Collins GB, McAllister MS. Chloroquine psychosis masquerading as PCP: a case report. J Psychoactive Drugs. 2008;40:211–4.PubMedCrossRef Collins GB, McAllister MS. Chloroquine psychosis masquerading as PCP: a case report. J Psychoactive Drugs. 2008;40:211–4.PubMedCrossRef
189.
go back to reference Nevin RL. Mefloquine and posttraumatic stress disorder. In: Ritchie EC, editor. Textbook of military medicine. Forensic and ethical issues in military behavioral health. Washington, DC: Borden Institute; 2015. p. 277–96. Nevin RL. Mefloquine and posttraumatic stress disorder. In: Ritchie EC, editor. Textbook of military medicine. Forensic and ethical issues in military behavioral health. Washington, DC: Borden Institute; 2015. p. 277–96.
190.
go back to reference Nevin RL, Byrd AM. Neuropsychiatric adverse reactions to mefloquine: a sysmetic comparison of prescribing and patient safety guidance in the US, UK, Ireland, Australia, New Zealand, and Canada. Neurol Ther. 2016. doi:10.1007/s40120-016-0045-5.PubMed Nevin RL, Byrd AM. Neuropsychiatric adverse reactions to mefloquine: a sysmetic comparison of prescribing and patient safety guidance in the US, UK, Ireland, Australia, New Zealand, and Canada. Neurol Ther. 2016. doi:10.​1007/​s40120-016-0045-5.PubMed
191.
go back to reference Ritchie EC, Block J, Nevin RL. Psychiatric side effects of mefloquine: applications to forensic psychiatry. J Am Acad Psychiatry Law. 2013;41:224–35.PubMed Ritchie EC, Block J, Nevin RL. Psychiatric side effects of mefloquine: applications to forensic psychiatry. J Am Acad Psychiatry Law. 2013;41:224–35.PubMed
192.
go back to reference Recasens C, Zittoun C, Féline A. A psychotic episode in a patient coming home from Africa: the possible role of mefloquine. Ann Psychiatr. 1993;8:100–3 (in French). Recasens C, Zittoun C, Féline A. A psychotic episode in a patient coming home from Africa: the possible role of mefloquine. Ann Psychiatr. 1993;8:100–3 (in French).
193.
go back to reference Hennequin C, Bourée P, Bazin N, Bisaro F, Feline A. Severe psychiatric side effects observed during prophylaxis and treatment with mefloquine. Arch Intern Med. 1994;154:2360–2.PubMedCrossRef Hennequin C, Bourée P, Bazin N, Bisaro F, Feline A. Severe psychiatric side effects observed during prophylaxis and treatment with mefloquine. Arch Intern Med. 1994;154:2360–2.PubMedCrossRef
194.
go back to reference Oueriagli Nahib F, Touhami M, Laffinti A, Abilkacem L. Mood disorder after malaria prophylaxis with mefloquine (two case reports). Encephale. 2011;37:393–6 (in French).CrossRef Oueriagli Nahib F, Touhami M, Laffinti A, Abilkacem L. Mood disorder after malaria prophylaxis with mefloquine (two case reports). Encephale. 2011;37:393–6 (in French).CrossRef
196.
go back to reference Clattenburg RN, Donnelly CL. Case study: neuropsychiatric symptoms associated with the antimalarial agent mefloquine. J Am Acad Child Adolesc Psychiatry. 1997;36:1606–8.PubMed Clattenburg RN, Donnelly CL. Case study: neuropsychiatric symptoms associated with the antimalarial agent mefloquine. J Am Acad Child Adolesc Psychiatry. 1997;36:1606–8.PubMed
197.
go back to reference Weinke T, Trautmann M, Held T, Weber G, Eichenlaub D, Fleischer K, et al. Neuropsychiatric side effects after the use of mefloquine. Am J Trop Med Hyg. 1991;45:86–91.PubMed Weinke T, Trautmann M, Held T, Weber G, Eichenlaub D, Fleischer K, et al. Neuropsychiatric side effects after the use of mefloquine. Am J Trop Med Hyg. 1991;45:86–91.PubMed
198.
go back to reference Nevin RL. Limbic encephalopathy and central vestibulopathy caused by mefloquine: a case report. Travel Med Infect Dis. 2012;10:144–51.PubMedCrossRef Nevin RL. Limbic encephalopathy and central vestibulopathy caused by mefloquine: a case report. Travel Med Infect Dis. 2012;10:144–51.PubMedCrossRef
199.
200.
go back to reference Dietz A, Frölich L. Mefloquine-induced paranoid psychosis and subsequent major depression in a 25-year-old student. Pharmacopsychiatry. 2002;35:200–2.PubMedCrossRef Dietz A, Frölich L. Mefloquine-induced paranoid psychosis and subsequent major depression in a 25-year-old student. Pharmacopsychiatry. 2002;35:200–2.PubMedCrossRef
201.
go back to reference Peterson AL, Seegmiller RA, Schindler LS. Severe neuropsychiatric reaction in a deployed military member after prophylactic mefloquine. Case Rep Psychiatry. 2011;2011:350417.PubMedPubMedCentral Peterson AL, Seegmiller RA, Schindler LS. Severe neuropsychiatric reaction in a deployed military member after prophylactic mefloquine. Case Rep Psychiatry. 2011;2011:350417.PubMedPubMedCentral
202.
go back to reference Tor PC, Lee HY, Tan CH. Mefloquine-induced mania in a 22-year-old Chinese man. Singapore Med J. 2006;47:549–50.PubMed Tor PC, Lee HY, Tan CH. Mefloquine-induced mania in a 22-year-old Chinese man. Singapore Med J. 2006;47:549–50.PubMed
203.
go back to reference Folkerts H, Kuhs H. [Psychotic episode caused by prevention of malaria with mefloquine. A case report. Nervenarzt. 1992;63:300–2 (in German).PubMed Folkerts H, Kuhs H. [Psychotic episode caused by prevention of malaria with mefloquine. A case report. Nervenarzt. 1992;63:300–2 (in German).PubMed
205.
go back to reference Nevin RL. Organic depersonalization as a chronic sequela of mefloquine intoxication. Psychosomatics. 2015;56:103–5.PubMedCrossRef Nevin RL. Organic depersonalization as a chronic sequela of mefloquine intoxication. Psychosomatics. 2015;56:103–5.PubMedCrossRef
206.
go back to reference Carme B, Nevez G, Peguet C, Bories C, Andrejak M. Neuropsychiatric intolerance during mefloquine prophylaxis. 5 case reports. Médecine Mal Infect. 1996;26:728–9 (in French).CrossRef Carme B, Nevez G, Peguet C, Bories C, Andrejak M. Neuropsychiatric intolerance during mefloquine prophylaxis. 5 case reports. Médecine Mal Infect. 1996;26:728–9 (in French).CrossRef
207.
go back to reference van Puijenbroek EP, Meyboom RHB. Sleep disorders during mefloquine use. Pharmaceutisch Weekblad. 1995;130:477–9 (in Dutch). van Puijenbroek EP, Meyboom RHB. Sleep disorders during mefloquine use. Pharmaceutisch Weekblad. 1995;130:477–9 (in Dutch).
209.
go back to reference Boudreau E, Schuster B, Sanchez J, Novakowski W, Johnson R, Redmond D, Hanson R, Dausel L. Tolerability of prophylactic Lariam regimens. Trop Med Parasitol. 1993;44:257–65.PubMed Boudreau E, Schuster B, Sanchez J, Novakowski W, Johnson R, Redmond D, Hanson R, Dausel L. Tolerability of prophylactic Lariam regimens. Trop Med Parasitol. 1993;44:257–65.PubMed
211.
go back to reference Arznei-Telegramm. Psychoses, suicides, etcetera. Should mefloquine (Lariam) still be allowed? Arznei-Telegramm. 2002;33:89. Arznei-Telegramm. Psychoses, suicides, etcetera. Should mefloquine (Lariam) still be allowed? Arznei-Telegramm. 2002;33:89.
212.
go back to reference Nevin RL. Hallucinations and persecutory delusions in mefloquine-associated suicide. Am J Forensic Med Pathol. 2012;33:e8.PubMedCrossRef Nevin RL. Hallucinations and persecutory delusions in mefloquine-associated suicide. Am J Forensic Med Pathol. 2012;33:e8.PubMedCrossRef
213.
go back to reference Scrip. Roche’s Lariam linked to a suicide in UK. Scrip. 1998;2321:23. Scrip. Roche’s Lariam linked to a suicide in UK. Scrip. 1998;2321:23.
214.
go back to reference Nevin RL, Ritchie EC. The mefloquine intoxication syndrome: A significant potential confounder in the diagnosis and management of PTSD and other chronic deployment-related neuropsychiatric disorders. In: Ritchie EC, editor. Posttraumatic stress disorder and related disorders in combat veterans. Cham: Springer International Publishing; 2015. p. 257–78.CrossRef Nevin RL, Ritchie EC. The mefloquine intoxication syndrome: A significant potential confounder in the diagnosis and management of PTSD and other chronic deployment-related neuropsychiatric disorders. In: Ritchie EC, editor. Posttraumatic stress disorder and related disorders in combat veterans. Cham: Springer International Publishing; 2015. p. 257–78.CrossRef
215.
go back to reference Nevin RL. Issues in the prevention of malaria among women at war. In: Ritchie EC, Naclerio AL, editors. women at war. London: Oxford University Press; 2015. p. 93–119.CrossRef Nevin RL. Issues in the prevention of malaria among women at war. In: Ritchie EC, Naclerio AL, editors. women at war. London: Oxford University Press; 2015. p. 93–119.CrossRef
217.
go back to reference Lobel HO. Adverse health events and malaria prophylaxis. Healthwise Newsl Peace Corps Med Off Worldw. 1996;5:1–4. Lobel HO. Adverse health events and malaria prophylaxis. Healthwise Newsl Peace Corps Med Off Worldw. 1996;5:1–4.
218.
go back to reference Schlagenhauf P, Steffen R. Neuropsychiatric events and travel: do antimalarials play a role? J Travel Med. 2000;7:225–6.PubMedCrossRef Schlagenhauf P, Steffen R. Neuropsychiatric events and travel: do antimalarials play a role? J Travel Med. 2000;7:225–6.PubMedCrossRef
219.
go back to reference Levin A. FDA warning highlights mefloquine’s mental health risks. Psychiatric News. 2013;48:1. Levin A. FDA warning highlights mefloquine’s mental health risks. Psychiatric News. 2013;48:1.
220.
go back to reference Ringqvist Å, Bech P, Glenthøj B, Petersen E. Acute and long-term psychiatric side effects of mefloquine: a follow-up on Danish adverse event reports. Travel Med Infect Dis. 2015;13:80–8.PubMedCrossRef Ringqvist Å, Bech P, Glenthøj B, Petersen E. Acute and long-term psychiatric side effects of mefloquine: a follow-up on Danish adverse event reports. Travel Med Infect Dis. 2015;13:80–8.PubMedCrossRef
221.
go back to reference World Health Organization. Post-malaria neurological syndrome and mefloquine. WHO Drug Inf. 1996;10:177. World Health Organization. Post-malaria neurological syndrome and mefloquine. WHO Drug Inf. 1996;10:177.
222.
go back to reference The Science News-Letter. Germany’s new scientific researches reported. Synthetic rival to quinine. Sci News Lett. 1926;10:3. The Science News-Letter. Germany’s new scientific researches reported. Synthetic rival to quinine. Sci News Lett. 1926;10:3.
223.
go back to reference British Medical Journal. A synthetic remedy for malaria. BMJ. 1926;2:798–9. British Medical Journal. A synthetic remedy for malaria. BMJ. 1926;2:798–9.
224.
go back to reference Hardgrove M, Applebaum IL. Plasmochin toxicity; analysis of 258 cases. Ann Intern Med. 1946;25:103–12.PubMedCrossRef Hardgrove M, Applebaum IL. Plasmochin toxicity; analysis of 258 cases. Ann Intern Med. 1946;25:103–12.PubMedCrossRef
225.
go back to reference Loken AC, Haymaker W. Pamaquine poisoning in man, with a clinicopathologic study of one case. Am J Trop Med Hyg. 1949;29:341–52.PubMed Loken AC, Haymaker W. Pamaquine poisoning in man, with a clinicopathologic study of one case. Am J Trop Med Hyg. 1949;29:341–52.PubMed
226.
go back to reference Schmidt IG, Schmidt LH. Neurotoxicity of the 8-aminoquinolines. I. Lesions in the central nervous system of the Rhesus monkey induced by administration of plasmocid. J Neuropathol Exp Neurol. 1948;7:368–98.PubMedCrossRef Schmidt IG, Schmidt LH. Neurotoxicity of the 8-aminoquinolines. I. Lesions in the central nervous system of the Rhesus monkey induced by administration of plasmocid. J Neuropathol Exp Neurol. 1948;7:368–98.PubMedCrossRef
227.
go back to reference Schmidt IG, Schmidt LH. Neurotoxicity of the 8-aminoquinolines. II. Reactions of various experimental animals to plasmocid. J Comp Neurol. 1949;91:337–67.PubMedCrossRef Schmidt IG, Schmidt LH. Neurotoxicity of the 8-aminoquinolines. II. Reactions of various experimental animals to plasmocid. J Comp Neurol. 1949;91:337–67.PubMedCrossRef
228.
go back to reference Schmidt IG, Schmidt LH. Neurotoxicity of the 8-aminoquinolines. III. The effects of pentaquine, isopentaquine, primaquine, and pamaquine on the central nervous system of the rhesus monkey. J Neuropathol Exp Neurol. 1951;10:231–56.PubMedCrossRef Schmidt IG, Schmidt LH. Neurotoxicity of the 8-aminoquinolines. III. The effects of pentaquine, isopentaquine, primaquine, and pamaquine on the central nervous system of the rhesus monkey. J Neuropathol Exp Neurol. 1951;10:231–56.PubMedCrossRef
229.
go back to reference West JB, Henderson AB. Plasmochin intoxication. Bull US Army Med Dep. 1944;82:87–99. West JB, Henderson AB. Plasmochin intoxication. Bull US Army Med Dep. 1944;82:87–99.
230.
go back to reference Findlay GM. Toxic reactions to antimalarial drugs. In: Findlay GM, editor. Recent advances in chemotherapy, vol. 2. Philadelphia: The Blakiston Company; 1950. p. 187–269. Findlay GM. Toxic reactions to antimalarial drugs. In: Findlay GM, editor. Recent advances in chemotherapy, vol. 2. Philadelphia: The Blakiston Company; 1950. p. 187–269.
231.
go back to reference Hill DR, Baird JK, Parise ME, Lewis LS, Ryan ET, Magill AJ. Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. Am J Trop Med Hyg. 2006;75:402–15.PubMed Hill DR, Baird JK, Parise ME, Lewis LS, Ryan ET, Magill AJ. Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. Am J Trop Med Hyg. 2006;75:402–15.PubMed
233.
go back to reference Vale N, Moreira R, Gomes P. Primaquine revisited six decades after its discovery. Eur J Med Chem. 2009;44:937–53.PubMedCrossRef Vale N, Moreira R, Gomes P. Primaquine revisited six decades after its discovery. Eur J Med Chem. 2009;44:937–53.PubMedCrossRef
235.
go back to reference Nasveld PE. Tafenoquine in the prophylaxis and treatment of malaria in Australian defence force personnel [Thesis]. James Cook University. 2011. Nasveld PE. Tafenoquine in the prophylaxis and treatment of malaria in Australian defence force personnel [Thesis]. James Cook University. 2011.
236.
go back to reference Milhous WK. Development of new drugs for chemoprophylaxis of malaria. Médecine Trop. 2001;61:48–50. Milhous WK. Development of new drugs for chemoprophylaxis of malaria. Médecine Trop. 2001;61:48–50.
237.
go back to reference Walsh DS, Looareesuwan S, Wilairatana P, Heppner DG, Tang DB, Brewer TG, et al. Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand. J Infect Dis. 1999;180:1282–7.PubMedCrossRef Walsh DS, Looareesuwan S, Wilairatana P, Heppner DG, Tang DB, Brewer TG, et al. Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand. J Infect Dis. 1999;180:1282–7.PubMedCrossRef
238.
go back to reference Nasveld PE, Edstein MD, Reid M, Brennan L, Harris IE, Kitchener SJ, et al. Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects. Antimicrob Agents Chemother. 2010;54:792–8.PubMedCrossRef Nasveld PE, Edstein MD, Reid M, Brennan L, Harris IE, Kitchener SJ, et al. Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects. Antimicrob Agents Chemother. 2010;54:792–8.PubMedCrossRef
239.
go back to reference Charles BG, Miller AK, Nasveld PE, Reid MG, Harris IE, Edstein MD. Population pharmacokinetics of tafenoquine during malaria prophylaxis in healthy subjects. Antimicrob Agents Chemother. 2007;51:2709–15.PubMedPubMedCentralCrossRef Charles BG, Miller AK, Nasveld PE, Reid MG, Harris IE, Edstein MD. Population pharmacokinetics of tafenoquine during malaria prophylaxis in healthy subjects. Antimicrob Agents Chemother. 2007;51:2709–15.PubMedPubMedCentralCrossRef
240.
go back to reference Bunnag D, Karbwang J, Viravan C, Chitamas S, Harinasuta T. Clinical trials of mefloquine with tetracycline. Southeast Asian J Trop Med Public Health. 1992;23:377–82.PubMed Bunnag D, Karbwang J, Viravan C, Chitamas S, Harinasuta T. Clinical trials of mefloquine with tetracycline. Southeast Asian J Trop Med Public Health. 1992;23:377–82.PubMed
241.
go back to reference Willerson D, Rieckmann KH, Carson PE, Frischer H. Effects of minocycline against chloroquine-resistant falciparum malaria. Am J Trop Med Hyg. 1972;21:857–62.PubMed Willerson D, Rieckmann KH, Carson PE, Frischer H. Effects of minocycline against chloroquine-resistant falciparum malaria. Am J Trop Med Hyg. 1972;21:857–62.PubMed
243.
go back to reference Tan KR, Magill AJ, Parise ME, Arguin PM. Doxycycline for malaria chemoprophylaxis and treatment: report from the CDC expert meeting on malaria chemoprophylaxis. Am J Trop Med Hyg. 2011;84:517–31.PubMedPubMedCentralCrossRef Tan KR, Magill AJ, Parise ME, Arguin PM. Doxycycline for malaria chemoprophylaxis and treatment: report from the CDC expert meeting on malaria chemoprophylaxis. Am J Trop Med Hyg. 2011;84:517–31.PubMedPubMedCentralCrossRef
245.
go back to reference Wallace MR, Sharp TW, Smoak B, Iriye C, Rozmajzl P, Thornton SA, et al. Malaria among United States troops in Somalia. Am J Med. 1996;100:49–55.PubMedCrossRef Wallace MR, Sharp TW, Smoak B, Iriye C, Rozmajzl P, Thornton SA, et al. Malaria among United States troops in Somalia. Am J Med. 1996;100:49–55.PubMedCrossRef
246.
go back to reference Ohrt C, Richie TL, Widjaja H, Shanks GD, Fitriadi J, Fryauff DJ, et al. Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1997;126:963–72.PubMedCrossRef Ohrt C, Richie TL, Widjaja H, Shanks GD, Fitriadi J, Fryauff DJ, et al. Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1997;126:963–72.PubMedCrossRef
247.
go back to reference Atigari OV, Hogan C, Healy D. Doxycycline and suicidality. BMJ Case Rep. 2013;2013:2013–5. Atigari OV, Hogan C, Healy D. Doxycycline and suicidality. BMJ Case Rep. 2013;2013:2013–5.
248.
250.
go back to reference Steffen R, Fuchs E, Schildknecht J, Naef U, Funk M, Schlagenhauf P, et al. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa. Lancet. 1993;341:1299–303.PubMedCrossRef Steffen R, Fuchs E, Schildknecht J, Naef U, Funk M, Schlagenhauf P, et al. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa. Lancet. 1993;341:1299–303.PubMedCrossRef
251.
go back to reference Briand V, Bottero J, Noël H, Masse V, Cordel H, Guerra J, et al. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine–pyrimethamine with mefloquine. J Infect Dis. 2009;200:991–1001.PubMedCrossRef Briand V, Bottero J, Noël H, Masse V, Cordel H, Guerra J, et al. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine–pyrimethamine with mefloquine. J Infect Dis. 2009;200:991–1001.PubMedCrossRef
252.
go back to reference Boggild AK, Parise ME, Lewis LS, Kain KC. Atovaquone-proguanil: report from the CDC expert meeting on malaria chemoprophylaxis (II). Am J Trop Med Hyg. 2007;76:208–23.PubMed Boggild AK, Parise ME, Lewis LS, Kain KC. Atovaquone-proguanil: report from the CDC expert meeting on malaria chemoprophylaxis (II). Am J Trop Med Hyg. 2007;76:208–23.PubMed
253.
go back to reference Overbosch D, Schilthuis H, Bienzle U, Behrens RH, Kain KC, Clarke PD, et al. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study. Clin Infect Dis. 2001;33:1015–21.PubMedCrossRef Overbosch D, Schilthuis H, Bienzle U, Behrens RH, Kain KC, Clarke PD, et al. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study. Clin Infect Dis. 2001;33:1015–21.PubMedCrossRef
254.
go back to reference Camus D, Djossou F, Schilthuis HJ, Høgh B, Dutoit E, Malvy D, et al. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: results of an international, randomized, open-label study. Clin Infect Dis. 2004;38:1716–23.PubMedCrossRef Camus D, Djossou F, Schilthuis HJ, Høgh B, Dutoit E, Malvy D, et al. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: results of an international, randomized, open-label study. Clin Infect Dis. 2004;38:1716–23.PubMedCrossRef
255.
go back to reference Brewer TG, Grate SJ, Peggins J, Peter J, Petras JM, Levine BS, et al. Fatal neurotoxocity of arteether and artemether. Am J Trop Med Hyg. 1994;51:251–9.PubMed Brewer TG, Grate SJ, Peggins J, Peter J, Petras JM, Levine BS, et al. Fatal neurotoxocity of arteether and artemether. Am J Trop Med Hyg. 1994;51:251–9.PubMed
256.
257.
go back to reference Genovese RF, Newman DB. Understanding artemisinin-induced brainstem neurotoxicity. Arch Toxicol. 2008;82:379–85.PubMedCrossRef Genovese RF, Newman DB. Understanding artemisinin-induced brainstem neurotoxicity. Arch Toxicol. 2008;82:379–85.PubMedCrossRef
258.
go back to reference Medhi B, Patyar S, Rao RS, Byrav DSP, Prakash A. Pharmacokinetic and toxicological profile of artemisinin compounds: an update. Pharmacology. 2009;84:323–32.PubMedCrossRef Medhi B, Patyar S, Rao RS, Byrav DSP, Prakash A. Pharmacokinetic and toxicological profile of artemisinin compounds: an update. Pharmacology. 2009;84:323–32.PubMedCrossRef
259.
go back to reference Martín VR, Martínez CG, Mackenzie I, Schmutzhard J, Pace C, Lalloo DG, et al. Neuroauditory toxicity of artemisinin combination therapies-have safety concerns been addressed? Am J Trop Med Hyg. 2014;91:62–73.CrossRef Martín VR, Martínez CG, Mackenzie I, Schmutzhard J, Pace C, Lalloo DG, et al. Neuroauditory toxicity of artemisinin combination therapies-have safety concerns been addressed? Am J Trop Med Hyg. 2014;91:62–73.CrossRef
260.
261.
go back to reference Banek K, Lalani M, Staedke SG, Chandramohan D. Adherence to artemisinin-based combination therapy for the treatment of malaria: a systematic review of the evidence. Malar J. 2014;13:7.PubMedPubMedCentralCrossRef Banek K, Lalani M, Staedke SG, Chandramohan D. Adherence to artemisinin-based combination therapy for the treatment of malaria: a systematic review of the evidence. Malar J. 2014;13:7.PubMedPubMedCentralCrossRef
262.
go back to reference Angus B. Novel anti-malarial combinations and their toxicity. Expert Rev Clin Pharmacol. 2014;7:299–316.PubMedCrossRef Angus B. Novel anti-malarial combinations and their toxicity. Expert Rev Clin Pharmacol. 2014;7:299–316.PubMedCrossRef
Metadata
Title
Psychiatric effects of malaria and anti-malarial drugs: historical and modern perspectives
Authors
Remington L. Nevin
Ashley M. Croft
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2016
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-016-1391-6

Other articles of this Issue 1/2016

Malaria Journal 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.